Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cochrane on Use of TPO-RAs to Prevent, Treat CIT

Cochrane; 2017 Nov 27; Zhang, Chuai, Nie, et al

Evidence does not support the use of thrombopoietin receptor agonists (TPO-RAs) to prevent chemotherapy-induced thrombocytopenia (CIT) or its recurrence in patients with solid tumors, according to a Cochrane review of 6 trials involving 268 individuals.

When patients with normal platelet count before chemotherapy are given eltrombopag vs placebo to prevent CIT:

  • TPO-RAs may have little or no difference to the all-cause mortality (based on low-quality of evidence).
  • There is not enough evidence to determine whether TPO-RAs reduce the number of patients with any or severe bleeding episodes (very low quality of evidence).

When patients with low platelet counts during a chemotherapy cycle are given romiplostim vs placebo to prevent CIT recurrence, there is not enough evidence to determine whether TPO-RAs reduce the number of patients with any or severe bleeding episodes (very low quality of evidence).

Citation:

Zhang X, Chuai Y, Nie W, Wang A, Dai G. Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumors. Cochrane Database of Syst Rev. 2017, Issue 11. Art. No.: CD012035. doi:10.1002/14651858.CD012035.pub2.

This Week's Must Reads

Cochrane on Use of TPO-RAs to Prevent, Treat CIT, Cochrane; 2017 Nov 27; Zhang, Chuai, Nie, et al

Guideline on Preventing VTE in Pediatric Cancer, J Thromb Haemost; ePub 2017 Nov 27; Tullius, et al

Conditioning Regimens After HCT Compared in ALL, Biol Blood Marrow Transplant; ePub 2017 Nov 29; Kebriaei, et al

Acute Kidney Injury in Young Allo-HCT Recipients, Biol Blood Marrow Transplant; ePub 2017 Nov 28; Koh, et al

Moral Distress in HCT Professionals Evaluated, Biol Blood Marrow Transplant; ePub 2017 Nov 28; Neumann, et al

Must Reads in Bleeding Disorders

Cochrane on Use of TPO-RAs to Prevent, Treat CIT, Cochrane; 2017 Nov 27; Zhang, Chuai, Nie, et al

Guideline on Preventing VTE in Pediatric Cancer, J Thromb Haemost; ePub 2017 Nov 27; Tullius, et al

Which SCD Vaso-Occlusive Episode Protocol Is Best?, Am J Hematol; ePub 2017 Nov 10; Tanabe, et al

Custom Assay Screens for von Willebrand Disease, J Thromb Haemost; ePub 2017 Nov 23; Lehman, et al

Cochrane on EPO Therapy in Low Birth Weight Infants, Cochrane; 2017 Nov 16; Ohlsson, Aher